A

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Senior Manager - R&D Quality Assurance

Regulatory & Quality (Life Sciences)Posted on Nov 14
Full-time$135.4k - $183.2k

About the Job

Requirements

  • A bachelor's degree, preferably in life science, such as technology, biological science, pharmacy, or another health-related discipline, or equivalent qualification or clinical research experience.
  • Seven years of experience in GCP Quality Assurance, or similar experience working in GCP and clinical trials supporting pharmaceutical development.
  • Experience overseeing late-phase clinical trials.
  • Experience supporting and leading inspection-readiness efforts and direct inspection experience.
  • Extensive experience working with different Quality Assurance functions and knowledge of Auditing, Clinical Supply Chain, Clinical Operations, Monitoring, Regulatory Affairs, Clinical Research, Drug Safety, Data Management, Programming, and Statistics.
  • Strong working knowledge of GCP regulations and industry guidance, including FDA, EMA, and other national agencies.

Responsibilities

  • Independently perform the R&D QA Program Lead role for assigned clinical studies, providing Clinical Quality Assurance oversight in accordance with study protocols, company procedures, GCP requirements, and applicable local and international regulations, with escalation to the GCP QA Director as appropriate.
  • Provide quality oversight for assigned clinical studies, including identification, assessment, mitigation, and escalation of quality and compliance risks, and support the investigation and resolution of Quality Events and CAPAs.
  • Lead and support GCP audit activities, including investigator site, vendor, study, and process audits, as applicable, and ensure audit observations and associated corrective and preventive actions are appropriately addressed.
  • Lead inspection-readiness activities for assigned clinical studies, including coordination of QA and cross-functional activities, identification and mitigation of potential inspection risks, and preparation for FDA, EMA, PMDA, and other Health Authority inspections.
  • Establish and maintain effective working relationships with internal Alnylam Expertise Area leads, study teams, vendors, and external partners to support study quality, compliance, and inspection-readiness activities.
  • Maintain current knowledge of applicable global GCP regulations, regulatory guidance, and industry practices, and support continuous improvement of R&D QA processes, procedures, and tools, as applicable.
  • Provide guidance, coaching, and oversight to assigned junior R&D QA staff, as applicable, to support effective execution of assigned activities and continued development.

Desired Qualifications

  • A master's degree in a science, technology, or industry-related discipline is preferred.
  • Experience leading audits is preferred.

About the Company

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Alnylam Pharmaceuticals develops RNA interference (RNAi) therapeutics to silence disease-causing genes, aiming to treat rare genetic disorders. Its products work by using RNA molecules that block gene expression, reducing the impact of specific genetic diseases. The company differentiates itself by concentrating on RNAi-based drugs for rare diseases and by building a pipeline through large clinical programs and strategic partnerships, such as commercialization deals in the Gulf States and collaborations with investors. Revenue comes from approved drug sales, licensing agreements, strategic collaborations, and related services like genetic testing and counseling. The company’s goal is to advance and commercialize RNAi therapies to improve outcomes for patients with genetic disorders, expanding its portfolio through partnerships and investments.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2002

Recently Posted Jobs

Explore more opportunities at Alnylam Pharmaceuticals

See more jobs